Sweet Syndrome Following SARS-CoV2 Vaccination

Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Baffa, Maria Efenesia, Maglie, Roberto, Giovannozzi, Neri, Montefusco, Francesca, Senatore, Stefano, Massi, Daniela, Antiga, Emiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622799/
https://www.ncbi.nlm.nih.gov/pubmed/34835143
http://dx.doi.org/10.3390/vaccines9111212
_version_ 1784605778684936192
author Baffa, Maria Efenesia
Maglie, Roberto
Giovannozzi, Neri
Montefusco, Francesca
Senatore, Stefano
Massi, Daniela
Antiga, Emiliano
author_facet Baffa, Maria Efenesia
Maglie, Roberto
Giovannozzi, Neri
Montefusco, Francesca
Senatore, Stefano
Massi, Daniela
Antiga, Emiliano
author_sort Baffa, Maria Efenesia
collection PubMed
description Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet’s syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet’s syndrome in this case.
format Online
Article
Text
id pubmed-8622799
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86227992021-11-27 Sweet Syndrome Following SARS-CoV2 Vaccination Baffa, Maria Efenesia Maglie, Roberto Giovannozzi, Neri Montefusco, Francesca Senatore, Stefano Massi, Daniela Antiga, Emiliano Vaccines (Basel) Case Report Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet’s syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet’s syndrome in this case. MDPI 2021-10-20 /pmc/articles/PMC8622799/ /pubmed/34835143 http://dx.doi.org/10.3390/vaccines9111212 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Baffa, Maria Efenesia
Maglie, Roberto
Giovannozzi, Neri
Montefusco, Francesca
Senatore, Stefano
Massi, Daniela
Antiga, Emiliano
Sweet Syndrome Following SARS-CoV2 Vaccination
title Sweet Syndrome Following SARS-CoV2 Vaccination
title_full Sweet Syndrome Following SARS-CoV2 Vaccination
title_fullStr Sweet Syndrome Following SARS-CoV2 Vaccination
title_full_unstemmed Sweet Syndrome Following SARS-CoV2 Vaccination
title_short Sweet Syndrome Following SARS-CoV2 Vaccination
title_sort sweet syndrome following sars-cov2 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622799/
https://www.ncbi.nlm.nih.gov/pubmed/34835143
http://dx.doi.org/10.3390/vaccines9111212
work_keys_str_mv AT baffamariaefenesia sweetsyndromefollowingsarscov2vaccination
AT maglieroberto sweetsyndromefollowingsarscov2vaccination
AT giovannozzineri sweetsyndromefollowingsarscov2vaccination
AT montefuscofrancesca sweetsyndromefollowingsarscov2vaccination
AT senatorestefano sweetsyndromefollowingsarscov2vaccination
AT massidaniela sweetsyndromefollowingsarscov2vaccination
AT antigaemiliano sweetsyndromefollowingsarscov2vaccination

Ejemplares similares